<DOC>
	<DOCNO>NCT01146366</DOCNO>
	<brief_summary>To prospectively look utility routine cervical mediastinoscopy ( lymph node biopsy ) patient clinically stag T2N0M0 NSCLC , well patient clinically stag T1N0M0 NSCLC high maxSUV primary tumor PET imaging . Hypothesis # 1 : The prevalence mediastinal lymph node metastases detectable cervical mediastinoscopy sufficiently low ( &lt; 10 % ) support routine use test study population . Hypothesis # 2 : The preoperative detection occult ( hide ) N2 lymph node metastases cervical mediastinoscopy patient clinically stag T2N0M0 NSCLC T1N0M0 NSCLC maxSUV &gt; 10 PET provide survival benefit compare detection occult N2 lymph node metastasis time thoracotomy use nodal dissection systematic sampling .</brief_summary>
	<brief_title>Utility Routine Cervical Mediastinoscopy Clinical Stage I Non-Small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Patients must proven suspect clinical stage I NSCLC . Clinical stage IA ( T1N0M0 ) patient allow participation maxSUV primary tumor &gt; /=10 . Clinical stage IB ( T2N0M0 ) must size criterion ( i.e . tumor must &gt; 3cm size . Patients T2 tumor visceral pleural involvement eligible study ) . 2 . Patients must surgical candidate least lobectomy anatomical resection ( via either videoassisted thoracoscopic surgery , open approach ) . 3 . Patient must ECOG/Zubrod score 0 , 1 2 . 4 . Patients must undergone previous invasive mediastinal staging cancer . 5 . Patients must tracheostomy . 6 . Patient must CT chest upper abdomen FDGPET scan perform within 60 day enrollment study confirm clinical stage I status . Both scan must perform , one need within 60 day enrollment study . There separately note exclusion criterion . All criterion list inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Early stage lung cancer</keyword>
	<keyword>Cervical mediastinoscopy</keyword>
	<keyword>Observational study</keyword>
	<keyword>clinical stage T2N0M0 select T1N0M0 ( suvMAX FDG-PET &gt; /=10 )</keyword>
</DOC>